Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Vitamin B12 Market Price & Analysis > Featured News - Vitamin B12 > Huaheng Biotechnology obtains IPO approval, leading alanine manufacturing to sprint into the capital market
— Share —

Huaheng Biotechnology obtains IPO approval, leading alanine manufacturing to sprint into the capital market

healthoo 2021-03-24
On March 23, according to the China Securities Regulatory Commission, Anhui Huaheng Biotechnology Co., Ltd.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.